![C13h13No5 1h-Pyrano [3,4-F] indolifine, 3,6,10 (4h) -trione, IV-ethyl-7,8-dihydro-4ci, aci) H319, H301](http://cdn.globalso.com/nvchem/style/global/img/demo/page_banner.jpg)
![C13h13No5 1h-Pyrano [3,4-F] indolizine, 3,6,10 (4h) -trione, IV-ethyl-7,8-dihydro-4ci, aci) H319, H302 Featured image) H319](https://cdn.globalso.com/nvchem/C13H13NO5-1H-Pyrano.jpg)
C13h13No5 1h-Pyrano [3,4-F] indolifine, 3,6,10 (4h) -trione, IV-ethyl-7,8-dihydro-4ci, aci) H319, H301
| Key physica proprietatibus | Valor | Conditio |
| Pondus | 263,25 | - |
| Melting Point (experimentalem) | 177.1-178.3 ° C | - |
| Ferveret (praedicta) | 666,6 ± 55.0 ° | Press: DCCLX Torr |
| Density (praedicta) | 1.50 ± 0.1 G / CM3 | Temp: XX ° C; Press: DCCLX Torr |
| Pka (praedicta) | 11,20 ± 0.20 | Most Acidic Temp: XXV ° C |
Canonica risum ridet o = c1c2 = c (c = c3c (= o) ccn13) C (o) (C (= o) OC2) CC
Isomerici risum dat C (C) [C @] I (o) C2 = c (C (o) N3C (= C2) C (= o) c3) Coc1 = o
INCHI
Inchi = 1s / c13h13No5 / C1-2-13 (XVIII) 8-5-9-10 (XV) 3-4-14 (IX) XI (XVI) VII (VIII) 6-19-12 (XIII) XVII / H5,18h, 2-4,6H2,1H3 / T13- / M0 / S1 / M0 / S1
Key Inchi
Igkwogmvaoyvsj, zdusscgksa, n
V Alia nomina pro hac substantia
(4s) -4, ethyl-7,8-dihydro-IV-hydroxy-1h-Pyrano [3,4-F] indolizine, 3,6,10 (4h) -trione (aci); 1h-Pyrano [3,4-F] indolizine, 3,6,10 (4h) -trione, 4- ethyl-7,8-Dihydro-IV-hydroxy-, (s) - (zci); (4s) -4-ethyl, IV-hydroxy, 7,8-dihydro-1h-Pyrano [3,4-F] indolizine, 3,6,10 (4h) Trion; (4s) -4, ethyl, 4-
Hydroxy, 7,8-Dihydro-1h-Pyrano [3,4-F] indolizine, 3,6,10, Trionis; (S) -4-ethyl, IV-hydroxy, 7,8-dihydro-1h-Pyrano [3,4-F] indolizine, 3,6,10 (4h) -trione
| Proprietatibus praesto |
| Optical et spargere |
| Scelerum |
Optical et spargere
| Res | Valor | Conditio | Fons |
| Rotatory Powtical | +10.6 deg | C: 0.62 G / 100ml; Solvente: Chloroform | (I) IC |
| Rotatory Powtical | +10.57 deg | C: 0.62 G / 100ml; Solvente: Chloroform; Temp: XX ° C | (II) IC |
| Rotatory Powtical | Deg +119.57 | C. 1.0 G / 100ml; Solvente: Chloroform; Λ: 589.3 NM; Temp: XXV ° C | (III) CAS |
| Rotatory Powtical | ML09.57 gradus · ml / g · dm | C. 1.0 G / 100ml; Solvente: Chloroform; Λ Sodium D acies; Temp: XXV ° C | (IV) CAS |
| Rotatory Powtical | Deg +117.6 | C. 0.56 G / 100ml; Solvente: Chloroform; Temp: XXIII ° C | (V) IC |
| Rotatory Powtical | +116.14 gradus · ml / g · dm | C. 1.0 G / 100ml; Solvente: Chloroform; Λ Sodium D acies; Temp: XXVI ° C | (IV) CAS |
| Rotatory Powtical | XVI Deg | C: 0.40 G / 100ml; Temp: XXI ° C | (VI) IC |
| Rotatory Powtical | +77.8 Deg | C: 0.62 G / 100ml; Solvente: Chloroform; Λ: 589.3 NM; Temp: XXV ° C | (VII) CAS |
(I) Terasawa, Hirofumi; Donec & PHARMACEUTICAL (MCMLXXXIX), XXXVII (XII), 3382-5, Caplus
(II) Tagawa, Hiroaki; Ep220601, A1, MCMLXXXVII, Caplus
(III) Henegar, Kevin E.; Journal de Organic Chymicis (MCMXCVII), LXII (XIX), 6588-6597, Caplus
(IV) Watanabe, Tatsuya; Quaestiones - An Asian Journal, (MMXIII), VIII (III), 630-638, Caplus
(V) Ejima, Akio; Journal de eget Society, Perkkkin Transactions I: Organic et Bio-Organic Chymicis (1972-1999), (MCMXC) (I), 27-31, Caplus
(VI) Wani, Mansukh c.; Journal de medicinalibus Quaestiones (MCMLXXXVII), XXX (XII), 2317-19, Caplus
(VII) Kuang, Yun Yan; Helvetica Chimica Acta (MMX), XCIII (X), 2094-2099, Caplus
Scelerum
| Res | Valor | Conditio | Fons | |
| Point liquescens | 183-185 ° C (Decomp) | (I) CAS | ||
| Point liquescens | 177.1-178.3 ° C | (II) CAS | ||
| Point liquescens | 176-177 ° C (Decomp) | (III) IC | ||
| Point liquescens | 169-170 ° C | Solvente: | Ethyl acetate | (IV) IC |
(I) Kuang, Yun Yan; Helvetica Chimica Acta (MMX), XCIII (X), 2094-2099, Caplus
(II) Henegar, Kevin E.; Journal de Organic Chymicis (MCMXCVII), LXII (XIX), 6588-6597, Caplus
(III) Ejima, Akio; Journal de eget Society, Perkkkin Transactions I: Organic et Bio-Organic Chymicis (1972-1999), (MCMXC) (I), 27-31, Caplus
(IV) Wani, Mansukh c.; Journal de medicinalibus Quaestiones (MCMLXXXVII), XXX (XII), 2317-19, Caplus
Spectra praesto
1h NMR
Missa
| Proprietatibus praesto |
| Biological |
| Proiectus |
| Densitas |
| Lipinski |
| Structuram related |
| Scelerum |
Biological
| Res | Valor | Conditio | Fons |
| Bioconcentration factor | 1.0 | PH I; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | PH II; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | PH III; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | PH IV; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | PH V; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | Ph VI; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | PH VII; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | PH VIII; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | PH IX; Temp: XXV ° C | (I) ACD |
| Bioconcentration factor | 1.0 | PH X; Temp: XXV ° C | (I) ACD |
(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)
Proiectus
| Res | Valor | Conditio | Fons |
| Koc | 7.37 | PH I; Temp: XXV ° C | (I) ACD |
| Koc | 7.37 | PH II; Temp: XXV ° C | (I) ACD |
| Koc | 7.37 | PH III; Temp: XXV ° C | (I) ACD |
| Koc | 7.37 | PH IV; Temp: XXV ° C | (I) ACD |
| Koc | 7.37 | PH V; Temp: XXV ° C | (I) ACD |
| Koc | 7.37 | Ph VI; Temp: XXV ° C | (I) ACD |
| Koc | 7.37 | PH VII; Temp: XXV ° C | (I) ACD |
| Res | Valor | Conditio | Fons |
| Koc | 7.37 | PH VIII; Temp: XXV ° C | (I) ACD |
| Koc | 7.33 | PH IX; Temp: XXV ° C | (I) ACD |
| Koc | 6,94 | PH X; Temp: XXV ° C | (I) ACD |
| logd | -0.94 | PH I; Temp: XXV ° C | (I) ACD |
| logd | -0.94 | PH II; Temp: XXV ° C | (I) ACD |
| logd | -0.94 | PH III; Temp: XXV ° C | (I) ACD |
| logd | -0.94 | PH IV; Temp: XXV ° C | (I) ACD |
| logd | -0.94 | PH V; Temp: XXV ° C | (I) ACD |
| logd | -0.94 | Ph VI; Temp: XXV ° C | (I) ACD |
| logd | -0.94 | PH VII; Temp: XXV ° C | (I) ACD |
| logd | -0.94 | PH VIII; Temp: XXV ° C | (I) ACD |
| logd | -0.94 | PH IX; Temp: XXV ° C | (I) ACD |
| logd | -0.96 | PH X; Temp: XXV ° C | (I) ACD |
| logp | -0.936 ± 0.842 | Temp: XXV ° C | (I) ACD |
| Missam intrinsecam solubility | CCCLXXI g / l | Temp: XXV ° C | (I) ACD |
| Missam solubility | CCCLXXI g / l | PH I; Temp: XXV ° C | (I) ACD |
| Missam solubility | CCCLXXI g / l | PH II; Temp: XXV ° C | (I) ACD |
| Missam solubility | CCCLXXI g / l | PH III; Temp: XXV ° C | (I) ACD |
| Missam solubility | CCCLXXI g / l | PH IV; Temp: XXV ° C | (I) ACD |
| Missam solubility | CCCLXXI g / l | PH V; Temp: XXV ° C | (I) ACD |
| Missam solubility | CCCLXXI g / l | Ph VI; Temp: XXV ° C | (I) ACD |
| Missam solubility | CCCLXXI g / l | PH VII; Temp: XXV ° C | (I) ACD |
| Missam solubility | CCCLXXI g / l | PH VIII; Temp: XXV ° C | (I) ACD |
| Missam solubility | CCCLXXI g / l | PH IX; Temp: XXV ° C | (I) ACD |
| Missam solubility | CCCXCII G / l | PH X; Temp: XXV ° C | (I) ACD |
| Missam solubility | CCCLXXI g / l | Unbuffered aqua PH 5.53; Temp: XXV ° C | (I) ACD |
| Molaris intrinsecam solubility | 1,41 Mol / l | Temp: XXV ° C | (I) ACD |
| Molaris solubility | 1,41 Mol / l | PH I; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 1,41 Mol / l | PH II; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 1,41 Mol / l | PH III; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 1,41 Mol / l | PH IV; Temp: XXV ° C | (I) ACD |
| Molaris solubility | 1,41 Mol / l | PH V; Temp: XXV ° C | (I) ACD |
| Res | Valor | Conditio | Fons | |
| Molaris solubility | 1,41 Mol / l | Ph VI; Temp: XXV ° C | (I) ACD | |
| Molaris solubility | 1,41 Mol / l | PH VII; Temp: XXV ° C | (I) ACD | |
| Molaris solubility | 1,41 Mol / l | PH VIII; Temp: XXV ° C | (I) ACD | |
| Molaris solubility | 1,41 Mol / l | PH IX; Temp: XXV ° C | (I) ACD | |
| Molaris solubility | Mol 1,49 / l | PH X; Temp: XXV ° C | (I) ACD | |
| Molaris solubility | 1,41 Mol / l | Unbuffered aqua PH 5.53; Temp: XXV ° C | (I) ACD | |
| Pondus | 263,25 | |||
| PKA | 11,20 ± 0.20 | Most Acidic Temp: XXV ° C | (I) ACD | |
| PKA | -2.24 ± 0.40 | Maxime basic temp: XXV ° | (I) ACD | |
| Vapor | 10-20 X 1.29 | Torr | Temp: XXV ° C | (I) ACD |
(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)
Densitas
| Res | Valor | Conditio | Fons |
| Densitas | 1.50 ± 0.1 G / CM3 | Temp: XX ° C; Press: DCCLX Torr | (I) ACD |
| Molaris volumine | 174.8 ± 5.0 CM3 / mol | Temp: XX ° C; Press: DCCLX Torr | (I) ACD |
(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)
Lipinski
| Res | Valor | Conditio | Fons |
| Sponte Rotatable vincula | 2 | (I) ACD | |
| H acceptors | 6 | (I) ACD | |
| H donos | 1 | (I) ACD | |
| H donator / Acceptor Sum | 7 | (I) ACD | |
| logp | -0.936 ± 0.842 | Temp: XXV ° C | (I) ACD |
| Pondus | 263,25 |
(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)
Structuram related
| Res | Valor | Conditio | Fons |
| Polar superficies regio | A2 83,9 | (I) ACD | |
(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)
Scelerum
| Res | Valor | Conditio | Fons |
| PRAETERITUS | 666,6 ± 55.0 ° | Press: DCCLX Torr | (I) ACD |
| Enthalpy vaporation | 112,17 ± 6.0 KJ / Mol | Press: DCCLX Torr | (I) ACD |
| Flash Point | 357.0 ± 31.5 ° C | (I) ACD |
(I) Calculus in ratione progressionem progressionem (ACD / Labs) Software V11.02 (© 1994-2023 ACD / Labs)
Spectra praesto
1h NMR
13c NMR
| Codex | Aleam dicitur | Fons |
| H319 | Causa gravis oculus irritatio | Europae chemical Agency (ECA) Classification & Labeling Inventory - Notified Classification et Labeling - Most Clementine_Vulgate Vicimediorum Communium, European Chemical Agency (ECA) Classification & Labeling - Notified Classification and Labeling - Notifications Ordo - Most Suspendisse notifications - Most Suspendisse - Notifications |
| H302 | Nocivis, si absorbuit | Europae chemical Agency (ECA) Classification & Labeling Inventory - Notified Classification et Labeling - Most Clementine_Vulgate Vicimediorum Communium, European Chemical Agency (ECA) Classification & Labeling - Notified Classification and Labeling - Notifications Ordo - Most Suspendisse notifications - Most Suspendisse - Notifications |
Secretum Business Information: Public
| Regulatory synonyms | ||
| (S) -4, ethyl, IV-hydroxy, 7,8-dihydro-1h-pyranno (3,4-f) indolizine, 3,6,10 (4h) -trione | - | Gallus |
| (S) -4, ethyl, IV-hydroxy-7,8-dihydro-1h-pyranno [3,4-f] indolizine, 3,6,10 (4h) -trione -Trione | - | Gallus |
| (S) -4, ethyl, IV-hydroxy-7,8-dihydro-1h-Pyrano (3,4-F) Indolizin, 3,6,10 (4h) -trion | - | Danica German |
| (S) -4-ethyl, IV-hydroxy-7,8-dihydro-1h-Pyrano (3,4-F) Indolizine, 3,6,10 (4h) -trion | - | Batavica |
| (S) -4-ethyl-IV-hydroxy-7,8-dihydro-1h-Pyrano [3,4-F] indolizin, 3,6,10 (4h) -trion | - | Danica German |
| (S) -4, ethyl-IV-hydroxy-7,8-dihydro-1h-Pyrano [3,4-F] indolizine, 3,6,10 (4h) -trion | - | Batavica |
| (S) -4-ethyl, IV-hydroxy, 7,8-dihydro-1h-Pyrano [3,4-F] indolizine, 3,6,10 (4h) -trione | - | - |
| (S) -4 -4-IV-Hidroxi-7,8-Dihidro-1h-Pirano (3,4-F) 3,6,10 (4h) -triona | - | Portuguese, Spanish |
| (S) -4 -4-IV-Hidroxi-7,8-Dihidro-1h-Pirano [3,4-F] Indolizina, 3,6,10 (4h) -triona | - | Portuguese, Spanish |
| (S) -4 -4-IV-IDROSSI, 7,8-Diidro-1h-Pirano (3,4-F) Indolizin, 3,6,10 (4h) -trione | - | Italiae |
| (S) -4 -4-IV-IDROSSI, 7,8-Diidro-1h-Pirano [3,4-F] Indolizin, 3,6,10 (4h) -trione | - | Italiae |
| (S) -4-Etyl-IV-hydroxi-7,8-dihydro-1h-Pyrano (3,4-f) Indolizin, 3,6,10 (4h) -trion | - | SCELIDUS |
| (S) -4-Etyl-IV-hydroxi, 7,8-dihydro-1h-Pyrano [3,4-F] indolizin, 3,6,10 (4h) -trion | - | SCELIDUS |
| (S) -4, etyyli-IV-Hydroksi, 7,8-Dihydro-1h-Pyrano (3,4-F) Indolitsiini, 3,6,10 (4h) -trioni | - | Fennica |
| (S) -4, ETYYLI-IV-Hydroksi, 7,8-Dihydro-1h-Pyrano [3,4-F] indolitsiini, 3,6,10 (4h) -trioni | - | Fennica |
Details per patriam / International & Alii Album
Harmonized Code: (CCXCIII) CDXCIX patria / Regio Information Available
Europaeae Unionis Summary
EU vexillum
EU consuetudines Code CN: 29349990
![L-Ornithinamide, L-Valyly, N5- (Aminocarbonyl) -n- [4- (hydroxymethyl) Phenyl] - (9CI, ACI) H335, H319, H315, H302,](https://cdn.globalso.com/nvchem/L-Ornithinamide-300x300.jpg)
![C9h10n2o5 6h-Furo [II ', III, 4,5] Oxazolo [3,2-a] Pyrimidin-VI-unum, 2,3,3a, 2, 9a-TETRA-VI-Hydroxy-2- (Hydroxymethyl, III-Hydroxy-2R, 9a-TETRA-VI-Hydroxy-2R (Hydroxymethyl), Hydroxy-2R, 9a-TETRHA ydro-III-hydroxy-2r, 9a-TETRH-III-Hydroxy-2r, 9a-TETRH) - (2r, III R, 3as, 9ar) - (9c, 3as, 9ar) - (9c, 3s), 9AR) - (9c, 3as) - (9c, 3s), 9ar) - (9c, 3as)](https://cdn.globalso.com/nvchem/C9H10N2O5-6H-Furo-300x300.png)
![C21H21N3O6 Thymidine, α - [(I-Naphthalenylenylenyl) amino] - α -Oxo- (ACI)](https://cdn.globalso.com/nvchem/C21H21N3O6-Thymidine-300x300.png)
![C31H30N2O7 6h-Furo [II ', III, 4,5] Oxazolo [3,2-a] Pyrimidin-VI-unus, II - -2,3,3,, 9a-Tetraxy, III -2,3,3,3,3,3,3, (IV-0 -2,3,3,3,3,3a, (IV-Methyly -2,3,3, [IV-Tetraxy, Hydroxy, 7A, Tetraxy, III -2,3,3,, 9a-Tetraxy, III -2,3,3,-, 9a, Tetraxy, (2r, 3r, 3as, 9ar) - (9CI, ACI)](https://cdn.globalso.com/nvchem/C31H30N2O7-6H-Furo-300x300.jpg)
